<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: SWK Holdings Corporation (NASDAQ: SWKH)'s sale to Runway Growth Finance Corp. If you are a SWK shareholder, click here to learn more about your rights and options. 89bio, Inc. (NASDAQ: ETNB)'s sale to Roche. Under the terms of the proposed transaction, 89bio shareholders will receive $14.50 per share in cash at closing, plus a non-tradeable contingent value right to receive certain contingent payments of up to an aggregate of $6.00 per share in cash upon achievement of specified milestones. If you are an 89bio shareholder, click here to learn more about your legal rights and options. Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options. Verint Systems Inc. (NASDAQ: VRNT)'s sale to Thoma Bravo for $20.50 per share in cash. If you are a Verint shareholder, click here to learn more about your legal rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDE2Jk5ld3NJdGVtSWQ9TlkwMDU0OCZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMTYyMzU4UFJfTkVXU19VU1BSX19fX19OWTAwNTQ4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDE2Jk5ld3NJdGVtSWQ9TlkwMDU0OCZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMTYyMzU4UFJfTkVXU19VU1BSX19fX19OWTAwNTQ4"/></div> </div></div>

ETNB

SWKH

BRNS

VRNT

Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The investigations concern SWKH's sale to Runway Growth Finance Corp., ETNB's sale to Roche, BRNS's merger with Clywedog Therapeutics, and VRNT's sale to Thoma Bravo. Shareholders are encouraged to contact Halper Sadeh LLC for legal rights and options regarding these transactions.

23:58 ET SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders